157 related articles for article (PubMed ID: 31229682)
21. Altered glutamatergic response and functional connectivity in treatment resistant schizophrenia: the effect of riluzole and therapeutic implications.
Pillinger T; Rogdaki M; McCutcheon RA; Hathway P; Egerton A; Howes OD
Psychopharmacology (Berl); 2019 Jul; 236(7):1985-1997. PubMed ID: 30820633
[TBL] [Abstract][Full Text] [Related]
22. Positive psychotic symptoms are associated with divergent developmental trajectories of hippocampal volume during late adolescence in patients with 22q11DS.
Mancini V; Sandini C; Padula MC; Zöller D; Schneider M; Schaer M; Eliez S
Mol Psychiatry; 2020 Nov; 25(11):2844-2859. PubMed ID: 31164700
[TBL] [Abstract][Full Text] [Related]
23. Candidate genes and the behavioral phenotype in 22q11.2 deletion syndrome.
Prasad SE; Howley S; Murphy KC
Dev Disabil Res Rev; 2008; 14(1):26-34. PubMed ID: 18636634
[TBL] [Abstract][Full Text] [Related]
24. Contribution of congenital heart disease to neuropsychiatric outcome in school-age children with 22q11.2 deletion syndrome.
Yi JJ; Tang SX; McDonald-McGinn DM; Calkins ME; Whinna DA; Souders MC; Zackai EH; Goldmuntz E; Gaynor JW; Gur RC; Emanuel BS; Gur RE
Am J Med Genet B Neuropsychiatr Genet; 2014 Mar; 165B(2):137-47. PubMed ID: 24265253
[TBL] [Abstract][Full Text] [Related]
25. No evidence for the presence of genetic variants predisposing to psychotic disorders on the non-deleted 22q11.2 allele of VCFS patients.
Guipponi M; Santoni F; Schneider M; Gehrig C; Bustillo XB; Kates WR; Morrow B; Armando M; Vicari S; Sloan-Béna F; Gagnebin M; Shashi V; Hooper SR; Eliez S; Antonarakis SE
Transl Psychiatry; 2017 Feb; 7(2):e1039. PubMed ID: 28221368
[TBL] [Abstract][Full Text] [Related]
26. Cortical Morphology Differences in Subjects at Increased Vulnerability for Developing a Psychotic Disorder: A Comparison between Subjects with Ultra-High Risk and 22q11.2 Deletion Syndrome.
Bakker G; Caan MW; Vingerhoets WA; da Silva-Alves F; de Koning M; Boot E; Nieman DH; de Haan L; Bloemen OJ; Booij J; van Amelsvoort TA
PLoS One; 2016; 11(11):e0159928. PubMed ID: 27828960
[TBL] [Abstract][Full Text] [Related]
27. Psychotic symptoms in children and adolescents with 22q11.2 deletion syndrome: Neuropsychological and behavioral implications.
Debbané M; Glaser B; David MK; Feinstein C; Eliez S
Schizophr Res; 2006 Jun; 84(2-3):187-93. PubMed ID: 16545541
[TBL] [Abstract][Full Text] [Related]
28. Striatal dopamine release and impaired reinforcement learning in adults with 22q11.2 deletion syndrome.
van Duin EDA; Kasanova Z; Hernaus D; Ceccarini J; Heinzel A; Mottaghy F; Mohammadkhani-Shali S; Winz O; Frank M; Beck MCH; Booij J; Myin-Germeys I; van Amelsvoort T
Eur Neuropsychopharmacol; 2018 Jun; 28(6):732-742. PubMed ID: 29703646
[TBL] [Abstract][Full Text] [Related]
29. Hyperprolinemia is a risk factor for schizoaffective disorder.
Jacquet H; Demily C; Houy E; Hecketsweiler B; Bou J; Raux G; Lerond J; Allio G; Haouzir S; Tillaux A; Bellegou C; Fouldrin G; Delamillieure P; Ménard JF; Dollfus S; D'Amato T; Petit M; Thibaut F; Frébourg T; Campion D
Mol Psychiatry; 2005 May; 10(5):479-85. PubMed ID: 15494707
[TBL] [Abstract][Full Text] [Related]
30. Cortical Dysconnectivity Measured by Structural Covariance Is Associated With the Presence of Psychotic Symptoms in 22q11.2 Deletion Syndrome.
Sandini C; Scariati E; Padula MC; Schneider M; Schaer M; Van De Ville D; Eliez S
Biol Psychiatry Cogn Neurosci Neuroimaging; 2018 May; 3(5):433-442. PubMed ID: 29735153
[TBL] [Abstract][Full Text] [Related]
31. 22q11.2 deletion syndrome and schizophrenia.
Qin X; Chen J; Zhou T
Acta Biochim Biophys Sin (Shanghai); 2020 Dec; 52(11):1181-1190. PubMed ID: 33098288
[TBL] [Abstract][Full Text] [Related]
32. PRODH rs450046 and proline x COMT Val¹⁵⁸ Met interaction effects on intelligence and startle in adults with 22q11 deletion syndrome.
de Koning MB; van Duin ED; Boot E; Bloemen OJ; Bakker JA; Abel KM; van Amelsvoort TA
Psychopharmacology (Berl); 2015 Sep; 232(17):3111-22. PubMed ID: 26068888
[TBL] [Abstract][Full Text] [Related]
33. [Neurocognitive and psychiatric management of the 22q11.2 deletion syndrome].
Demily C; Rossi M; Schneider M; Edery P; Leleu A; d'Amato T; Franck N; Eliez S
Encephale; 2015 Jun; 41(3):266-73. PubMed ID: 25523123
[TBL] [Abstract][Full Text] [Related]
34. Long-term effects of early treatment with SSRIs on cognition and brain development in individuals with 22q11.2 deletion syndrome.
Mancini V; Maeder J; Bortolin K; Schneider M; Schaer M; Eliez S
Transl Psychiatry; 2021 May; 11(1):336. PubMed ID: 34052829
[TBL] [Abstract][Full Text] [Related]
35. Excitatory/Inhibitory Imbalance Underlies Hippocampal Atrophy in Individuals With 22q11.2 Deletion Syndrome With Psychotic Symptoms.
Mancini V; Saleh MG; Delavari F; Bagautdinova J; Eliez S
Biol Psychiatry; 2023 Oct; 94(7):569-579. PubMed ID: 37011759
[TBL] [Abstract][Full Text] [Related]
36. The Psychosis Spectrum in 22q11.2 Deletion Syndrome Is Comparable to That of Nondeleted Youths.
Tang SX; Moore TM; Calkins ME; Yi JJ; Savitt A; Kohler CG; Souders MC; Zackai EH; McDonald-McGinn DM; Emanuel BS; Gur RC; Gur RE
Biol Psychiatry; 2017 Jul; 82(1):17-25. PubMed ID: 27832840
[TBL] [Abstract][Full Text] [Related]
37. Basal ganglia calcification and psychosis in 22q11.2 deletion syndrome.
Sieberer M; Haltenhof H; Haubitz B; Pabst B; Miller K; Garlipp P
Eur Psychiatry; 2005 Dec; 20(8):567-9. PubMed ID: 15967641
[TBL] [Abstract][Full Text] [Related]
38. Musical auditory processing, cognition, and psychopathology in 22q11.2 deletion syndrome.
Gao L; Tang SX; Yi JJ; McDonald-McGinn DM; Zackai EH; Emanuel BS; Gur RC; Calkins ME; Gur RE
Am J Med Genet B Neuropsychiatr Genet; 2018 Dec; 177(8):765-773. PubMed ID: 30444066
[TBL] [Abstract][Full Text] [Related]
39. Predominant negative symptoms in 22q11.2 deletion syndrome and their associations with cognitive functioning and functional outcome.
Schneider M; Van der Linden M; Menghetti S; Glaser B; Debbané M; Eliez S
J Psychiatr Res; 2014 Jan; 48(1):86-93. PubMed ID: 24189154
[TBL] [Abstract][Full Text] [Related]
40. Cortical-amygdala volumetric ratios predict onset of symptoms of psychosis in 22q11.2 deletion syndrome.
Berhanu D; Mattiaccio LM; Antshel KM; Fremont W; Middleton FA; Kates WR
Psychiatry Res Neuroimaging; 2017 Jan; 259():10-15. PubMed ID: 27918911
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
